全文获取类型
收费全文 | 5686篇 |
免费 | 302篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 125篇 |
儿科学 | 326篇 |
妇产科学 | 125篇 |
基础医学 | 544篇 |
口腔科学 | 73篇 |
临床医学 | 308篇 |
内科学 | 1076篇 |
皮肤病学 | 110篇 |
神经病学 | 409篇 |
特种医学 | 178篇 |
外科学 | 891篇 |
综合类 | 275篇 |
预防医学 | 323篇 |
眼科学 | 270篇 |
药学 | 423篇 |
中国医学 | 18篇 |
肿瘤学 | 520篇 |
出版年
2022年 | 69篇 |
2021年 | 132篇 |
2020年 | 75篇 |
2019年 | 105篇 |
2018年 | 124篇 |
2017年 | 90篇 |
2016年 | 132篇 |
2015年 | 108篇 |
2014年 | 189篇 |
2013年 | 245篇 |
2012年 | 332篇 |
2011年 | 395篇 |
2010年 | 228篇 |
2009年 | 209篇 |
2008年 | 292篇 |
2007年 | 337篇 |
2006年 | 324篇 |
2005年 | 255篇 |
2004年 | 263篇 |
2003年 | 226篇 |
2002年 | 173篇 |
2001年 | 135篇 |
2000年 | 156篇 |
1999年 | 135篇 |
1998年 | 47篇 |
1997年 | 44篇 |
1996年 | 46篇 |
1995年 | 33篇 |
1993年 | 28篇 |
1992年 | 60篇 |
1991年 | 49篇 |
1990年 | 46篇 |
1989年 | 53篇 |
1988年 | 44篇 |
1987年 | 61篇 |
1986年 | 48篇 |
1985年 | 56篇 |
1984年 | 52篇 |
1983年 | 33篇 |
1979年 | 26篇 |
1978年 | 29篇 |
1977年 | 30篇 |
1974年 | 34篇 |
1973年 | 49篇 |
1972年 | 42篇 |
1971年 | 37篇 |
1970年 | 30篇 |
1969年 | 35篇 |
1968年 | 36篇 |
1967年 | 25篇 |
排序方式: 共有5994条查询结果,搜索用时 46 毫秒
991.
Philipp Saiko Geraldine Graser Benedikt Giessrigl Andreas Lackner Michael Grusch Georg Krupitza Arijit Basu Barij Nayan Sinha Venkatesan Jayaprakash Walter Jaeger Monika Fritzer-Szekeres Thomas Szekeres 《Biochemical pharmacology》2011,(1):50
Ribonucleotide reductase (RR; EC 1.17.4.1) is responsible for the de novo conversion of ribonucleoside diphosphates into deoxyribonucleoside diphosphates, which are essential for DNA replication. RR is upregulated in tumor cells and therefore considered to be an excellent target for cancer chemotherapy.ABNM-13 (N-hydroxy-2-(anthracene-2-yl-methylene)-hydrazinecarboximidamide), a novel N-hydroxy-N′-aminoguanidine has been designed to inhibit RR activity using 3D molecular space modeling techniques. In this study, we evaluated its effect on human HL-60 promyelocytic leukemia cells. ABNM-13 proved to be a potent inhibitor of RR which was displayed by significant alterations of deoxyribonucleoside triphosphate (dNTP) pool balance and a highly significant decrease of incorporation of radiolabeled cytidine into DNA of HL-60 cells. Diminished RR activity caused replication stress which was consistent with activation of Chk1 and Chk2, resulting in downregulation/degradation of Cdc25A. In contrast, Cdc25B was upregulated, leading to dephosphorylation and activation of Cdk1. The combined disregulation of Cdc25A and Cdc25B was the most likely cause for ABNM-13 induced S-phase arrest. Finally, we combined ABNM-13 with the first-line antileukemic agent arabinofuranosylcytosine (Ara-C) and found that ABNM-13 synergistically potentiated the antineoplastic effects of Ara-C.Due to these promising results, ABNM-13 deserves further preclinical and in vivo testing. 相似文献
992.
993.
Rachael Z Stolzenberg-Solomon Amanda J Cross Debra T Silverman Catherine Schairer Frances E Thompson Victor Kipnis Amy F Subar Albert Hollenbeck Arthur Schatzkin Rashmi Sinha 《Cancer epidemiology, biomarkers & prevention》2007,16(12):2664-2675
Meat intake, particularly red meat, has been positively associated with pancreatic cancer in some epidemiologic studies. Detailed meat-cooking methods and related mutagens formed in meat cooked at high temperatures have not been evaluated prospectively as risk factors for this malignancy. We investigated the association between meat, meat-cooking methods, meat-mutagen intake, and exocrine pancreatic cancer in the NIH-American Association of Retired Persons (NIH-AARP) Diet and Health Study cohort of 537,302 individuals, aged 50 to 71 years, with complete baseline dietary data (1995-1996) ascertained from a food frequency questionnaire. A meat-cooking module was completed by 332,913 individuals 6 months after baseline. During 5 years of follow-up, 836 incident pancreatic cancer cases (555 men, 281 women) were identified. Four hundred and fifty-nine cases had complete meat module data. We used Cox proportional hazard models to calculate hazard ratios (HR) and 95% confidence intervals (CI). Total, red, and high-temperature cooked meat intake was positively associated with pancreatic cancer among men (fifth versus first quintile: HR, 1.41, 95% CI, 1.08-1.83, P trend = 0.001; HR, 1.42, 95% CI, 1.05-1.91, P trend = 0.01; and HR, 1.52, 95% CI, 1.12-2.06, P trend = 0.005, respectively), but not women. Men showed significant 50% increased risks for the highest tertile of grilled/barbecued and broiled meat and significant doubling of risk for the highest quintile of overall meat-mutagenic activity (P trends < 0.01). The fifth quintile of the heterocyclic amine, 2-amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline intake showed a significant 29% (P trend = 0.006) increased risk in men and women combined. These findings support the hypothesis that meat intake, particularly meat cooked at high temperatures and associated mutagens, may play a role in pancreatic cancer development. 相似文献
994.
Sinha AK Anand S Ortel BJ Chang Y Mai Z Hasan T Maytin EV 《British journal of cancer》2006,95(4):485-495
Photodynamic therapy (PDT) using 5-aminolaevulinic acid (ALA) to drive production of an intracellular photosensitiser, protoporphyrin IX (PpIX), is a promising cancer treatment. However, ALA-PDT is still suboptimal for thick or refractory tumours. Searching for new approaches, we tested a known inducer of cellular differentiation, methotrexate (MTX), in combination with ALA-PDT in LNCaP cells. Methotrexate alone promoted growth arrest, differentiation, and apoptosis. Methotrexate pretreatment (1 mg l(-1), 72 h) followed by ALA (0.3 mM, 4 h) resulted in a three-fold increase in intracellular PpIX, by biochemical and confocal analyses. After exposure to 512 nm light, killing was significantly enhanced in MTX-preconditioned cells. The reverse order of treatments, ALA-PDT followed by MTX, yielded no enhancement. Methotrexate caused a similar relative increase in PpIX, whether cells were incubated with ALA, methyl-ALA, or hexyl-ALA, arguing against a major effect upon ALA transport. Searching for an effect among porphyrin synthetic enzymes, we found that coproporphyrinogen oxidase (CPO) was increased three-fold by MTX at the mRNA and protein levels. Transfection of LNCaP cells with a CPO-expressing vector stimulated the accumulation of PpIX. Our data suggest that MTX, when used to modulate intracellular production of endogenous PpIX, may provide a new combination PDT approach for certain cancers. 相似文献
995.
Girish GV Sinha N Chakraborty K Bhattacharya G Kahn NN Sinha AK 《Acta oncologica (Stockholm, Sweden)》2006,45(2):184-187
Maspin, an anti breast cancer protein, is produced in the normal mammary cells but not in malignant cells in breast cancer. We investigated the effect of aspirin induced increase of plasma nitric oxide (NO) on plasma maspin production in breast cancer patients. Fifteen breast cancer patients (35-65 years), who had not yet undergone any cancer therapy, and an equal number of age matched normal female volunteers participated in the study. They were asked not to take any medication for two weeks. All participants then ingested 150 mg of aspirin. Plasma NO and maspin levels were determined before and at 60 min after the ingestion of aspirin. It was found that the maspin level in plasma increased to 4.63+/-0.02 nM from the basal 0.95+/-0.012 nM (p<0.001) with increase of plasma NO from 0.60+/-0.03 microM to 2.08+/-0.030 microM (p<0.001) in breast cancer patients. In normal volunteers the basal maspin increased from 4.76+/-0.041 to 9.36+/-0.036 nM (p<0.001) with increase of NO from 2.15+/-0.08 to 3.36+/-0.04 microM (p<0.001) at the same period. These results indicated that the ingestion of aspirin might be beneficial for breast cancer through increased maspin production. 相似文献
996.
Sutapa Sinha Krishnendu Pal Ahmed Elkhanany Shamit Dutta Ying Cao Gourish Mondal Seethalakshmi Iyer Veena Somasundaram Fergus J. Couch Viji Shridhar Resham Bhattacharya Debabrata Mukhopadhyay Priya Srinivas 《International journal of cancer. Journal international du cancer》2013,132(5):1201-1212
Angiogenesis is a hallmark of tumor development and metastatic progression, and anti‐angiogenic drugs targeting the VEGF pathway have shown to decrease the disease progression in cancer patients. In this study, we have analyzed the anti‐proliferative and anti‐angiogenic property of plumbagin in cisplatin sensitive, BRCA2 deficient, PEO‐1 and cisplatin resistant, BRCA2 proficient PEO‐4 ovarian cancer cells. Both PEO‐1 and PEO‐4 ovarian cancer cells are sensitive to plumbagin irrespective of BRCA2 status in both normoxia and hypoxia. Importantly, plumbagin treatment effectively inhibits VEGF‐A and Glut‐1 in PEO‐1 and PEO‐4 ovarian cancer cells. We have also analyzed the p53 mutant, cisplatin resistant, and BRCA2 proficient OVCAR‐5 cells. Plumbagin challenge also restricts the VEGF induced pro‐angiogenic signaling in HUVECs and subsequently endothelial cell proliferation. In addition, we observe a significant effect on tumor regression among OVCAR‐5 tumor‐bearing mice treated with plumbagin, which is associated with significant inhibition of Ki67 and vWF expressions. Plumbagin also significantly reduces CD31 expression in an ear angiogenesis assay. Collectively, our studies indicate that plumbagin, as an anti‐cancer agent disrupts growth of ovarian cancer cells through the inhibition of proliferation as well as angiogenesis. 相似文献
997.
C T DellaValle C R Daniel B Aschebrook-Kilfoy A R Hollenbeck A J Cross R Sinha M H Ward 《British journal of cancer》2013,108(1):205-212
Background:
Nitrate and nitrite are present in many foods and are precursors of N-nitroso compounds, known animal carcinogens and potential human carcinogens. We prospectively investigated the association between nitrate and nitrite intake from dietary sources and risk of renal cell carcinoma (RCC) overall and clear cell and papillary histological subtypes in the NIH-AARP Diet and Health Study.Methods:
Nitrate and nitrite intakes were estimated from a 124-item food frequency questionnaire. Over a mean follow-up of 9 years, we identified 1816 RCC cases (n=498, clear cell; n=115, papillary cell) among 491 841 participants. Cox proportional hazard regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs).Results:
Individuals in the highest quintile of nitrite intake from animal sources compared with those in the lowest quintile, had an increased risk of total RCC and clear cell subtype (HR=1.28, 95% CI, 1.10–1.49 and HR=1.68, 95% CI, 1.25–2.27, respectively). Nitrite from processed meats and other animal sources were associated with increased clear cell adenocarcinoma risk (HR=1.33, 95% CI, 1.01–1.76 and HR=1.78, 95% CI, 1.34–2.36, respectively). We found no association for nitrite intake from plant sources or nitrate intake overall.Conclusion:
Our findings suggest that nitrite from animal sources may increase the risk of RCC, particularly clear cell adenocarcinomas. 相似文献998.
Vedang Murthy Shwetabh Sinha Sadhana Kannan Debanjali Datta Rabi Das Ganesh Bakshi Gagan Prakash Rahul Krishnatry 《Practical radiation oncology》2019,9(5):347-353
PurposeTo determine the genitourinary (GU) toxicity outcomes in prostate cancer patients treated with stereotactic body radiation therapy (SBRT) who have undergone a prior transurethral resection of prostate (TURP) and compare it to a similar non-TURP cohort.Materials and MethodsFifty prostate cancer patients who had undergone a single TURP, had a good baseline urinary function, and had been subsequently treated with SBRT were chosen from a prospectively maintained database. These were propensity score matched to a similar non-TURP cohort treated during the same period. Matching was done for diabetes mellitus and volume of radiation therapy. Acute GU and late GU toxicity were scored using the Radiation Therapy Oncology Group (RTOG) criteria. Stricture and incontinence were scored using Common Terminology for Common Adverse Events version 4.0.ResultsMedian follow-up for the entire cohort was 26 months (non-TURP vs TURP, 30 months vs 22 months, P = .34). The median duration between TURP and start of SBRT was 10 months. There was no significant difference between non-TURP versus TURP cohort in terms of RTOG acute GU toxicities grade ≥2 (8% vs 6%, P = .45), RTOG late GU toxicities grade ≥2 (8% vs 12%, P = .10), stricture rates (4% vs 6%, P = .64), and incontinence rates (0% vs 4%, P = .15). The median duration of time to late toxicity was 16 months vs 10 months (P = .12) in non-TURP and TURP cohort, respectively.ConclusionsAlthough modestly increased as compared with non-TURP patients, GU toxicities remains low with SBRT in post-TURP patients. SBRT can be safely performed in carefully selected post-TURP prostate cancer patients. 相似文献
999.
Sung Il Chang Karam El-Bayoumy Indu Sinha Neil Trushin Bruce Stanley Brian Pittman Bogdan Prokopczyk 《Cancer epidemiology, biomarkers & prevention》2007,16(2):228-235
The nicotine-derived nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is one of the most potent lung carcinogens in rodents. Several epidemiologic studies indicated that the development of lung cancer in smokers is influenced by the type and amount of dietary polyunsaturated fatty acids. A high corn oil diet has been shown to increase lung tumor volume and to decrease tumor latency in rats treated with NNK. In this study, we investigated the effects of dietary polyunsaturated fatty acids in the form of corn oil or fish oil on lung proteomes in F344 rats treated with or without NNK. The fish oil diet contained 17% fish oil and 3% corn oil, and the corn oil diet contained 20% corn oil. Rats were sacrificed after 3 months, and lungs were excised. Whole lung tissue proteins were separated by two-dimensional liquid chromatography, and differentially expressed proteins were identified by trypsin digestion and tandem mass spectrometry. Apolipoprotein A-I and Clara cell 17-kDa protein were overexpressed in the lungs of rats fed corn oil diet, compared with fish oil diet. NNK further enhanced their expression in rats fed corn oil diet; this effect was not observed in animals fed fish oil diet. The results suggest that the elevated levels of apolipoprotein A-I and Clara cell 17-kDa protein may be involved in the development of NNK-induced lung cancer in rats fed a high corn oil diet. Therefore, we propose that both proteins may serve as potential biomarkers in future molecular epidemiologic and clinical chemoprevention intervention studies. 相似文献
1000.
A Study on the Association of Cytochrome-P450 1A1 Polymorphism and Breast Cancer Risk in North Indian Women 总被引:10,自引:0,他引:10
Singh V Rastogi N Sinha A Kumar A Mathur N Singh MP 《Breast cancer research and treatment》2007,101(1):73-81
Cytochrome P-450 1A1 (CYP1A1) is involved in the 2-hydroxylation of estrogens and mammary carcinogens into 2-hydroxy catechol
metabolites. Many commonly occurring single nucleotide polymorphism (SNP) are reported in CYP1A1 in various populations that
include, isoleucine to valine substitution at 462 codon in heme binding region in exon 7 (A to G transition at position 2455;
M2), threonine to asparagine substitution at codon 461 (C to A transversion at position 2453; M4), T to C transition at 3801
position (M1) and T to C transition at position 3205 (M3) in 3′ non-coding region. Epidemiological studies have shown inconsistent
patterns between CYP1A1 polymorphism and breast cancer risk among various populations. Most of the studies have shown significant
association between CYP1A1 genotype polymorphism and breast cancer risk. The present investigation was therefore undertaken
to investigate the association of M1, M2, M3 and M4 polymorphisms and their subsequent contribution in premenopausal and postmenopausal
women with breast cancer risk in north Indian women. Genomic DNA was isolated from case controls and breast cancer patients,
specific segments of genomic DNA were amplified and restriction fragment length polymorphism (RFLP) was performed. CYP1A1
expression and catalytic activity were also assessed in premenopausal and postmenopausal case controls and patients. Polymorphism
at M1, M2 and M4 alleles was detected and odds ratio for W/M1 and␣M1/M1 was calculated as 1.07 (95% CI, 0.59–1.87) and 0.74
(95% CI, 0.28–1.96) respectively. Odds ratio for W/M1 and M1/M1 alleles in premenopausal and postmenopausal women was 1.09
(95% CI, 0.45–2.49)/0.62 (95% CI, 0.10–2.66) and 1.60 (95% CI, 0.60–4.22)/1.06 (95% CI, 0.22–7.33) respectively. Odds ratio
for W/M4 and M4/M4 allele was 1.20 (95% CI, 0.65–2.24)/4.55 (95% CI, 0.44–226.2) and 0.96 (95% CI, 0.36–2.64)/4.51 (95% CI,
0.23–273.0) respectively in total and premenopausal women. In postmenopausal women odds ratio was calculated as 1.16 (95%
CI, 0.45–2.94) for M4/W but it could not be detected for M4/M4 since this genotype was not found in any postmenopausal case
controls. Odds ratio for W/M2 genotype was calculated 0.57 (95% CI, 0.28–1.02), 1.06 (95% CI, 0.40–2.47) and 0.33 (95% CI,
0.12–0.89) respectively for total, premenopausal and postmenopausal women, however, in any group the odds ratio for M2/M2
could not be detected as M2/M2 genotype was not found in breast cancer patients. Polymorphism at M1 and M4 alleles was not
found significantly associated with breast cancer risk and only wild type genotype was found in case controls and patients
for M3 allele. Lack of protective association between CYP1A1 M2 genotype was also observed, however, in postmenopausal women
a significant protective association with breast cancer risk was found (odds ratio, 0.33; 95% CI, 0.12–0.89; P-value 0.03). Similarly, no significant alteration in CYP1A1 expression and catalytic activity was observed in wild type and
variant genotypes both in premenopausal and postmenopausal patients as compared with their respective controls. The results
obtained from the present investigation thus suggest that probably CYP1A1 (M1, M2, M3, and M4) polymorphism alone does not
play a significant role in the breast cancer risk in north Indian women. 相似文献